Atlas Trials

Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance

Clinical trial NCT00733174 · UNKNOWN

Trial details

NCT number
NCT00733174
Sponsor
Denver Research Institute
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Impaired Glucose Tolerance
Start date
2004-03-01
Primary completion
2009-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.